Search Results
Aug 03, 2026, 22:00 ET NOL World Luncurkan Platform Pemesanan Akomodasi bagi Penggemar K-Pop yang Berkunjung ke Korea Selatan
– Pengguna dapat mencari dan memesan akomodasi di sekitar lokasi konser K-pop melalui satu platform terpadu– Rayakan peluncuran layanan ini dengan diskon pemesanan akomodasi hingga 10% serta kupon tambahan 10% untuk berbagai tur dan aktivitas di Korea Selatan
More news about: NOL Universe
Aug 03, 2026, 22:00 ET NOL World ra mắt nền tảng đặt chỗ lưu trú dành cho người hâm mộ K-POP đến Hàn Quốc
– Tìm kiếm chỗ lưu trú gần các địa điểm tổ chức hòa nhạc K-POP lớn và đặt phòng từ mạng lưới cơ sở lưu trú phong phú – tất cả trên một nền tảng duy nhất– Chào mừng ra mắt với ưu đãi giảm giá độc quyền lên tới 10% khi đặt chỗ, cùng phiếu giảm giá bổ sung
More news about: NOL Universe
Aug 03, 2026, 21:27 ET Southern Company announces upsize and pricing of $725 million in aggregate principal amount of Series 2026A 2.125% Convertible Senior Notes due December 15, 2027 and $1.65 billion in aggregate principal amount of Series 2026B 3.50% Convertible Senior Notes due September 15, 2029
assurance that such suggested results will be realized. The following factors, in addition to those discussed in Southern Company's Annual Report on Form 10-K for the year ended December 31, 2025, Quarterly Reports on Form 10-Q for the quarters ended March 31, 2026 and June 30, 2026 and subsequent securities
More news about: Southern Company
Aug 03, 2026, 20:00 ET NOL World、宿泊予約サービスを開始 K-POPを目的とした韓国旅行をより便利に
Universe（代表取締役 イ・チョルウン）が運営する訪韓旅行者向けプラットフォーム NOL Worldは、韓国国内の宿泊予約サービスを開始しました。NOL Worldは、海外から韓国を訪れる旅行者が、K-POP公演チケット、宿泊、ツアー・アクティビティ、交通まで、韓国旅行に必要なサービスを1つのプラットフォームで予約できる訪韓旅行特化型サービスです。今回のサービス開始により、旅行者は韓国旅行の計画から予約までを、これまで以上にスムーズに行えるようになります。
More news about: NOL Universe
Aug 03, 2026, 18:13 ET Quanta Services Announces Pricing of Senior Notes Offering
supplement and accompanying base prospectus relating to the Offering and other risks and uncertainties detailed in Quanta's Annual Report on Form 10-K for the year ended December 31, 2025, Quanta's Quarterly Reports on Form 10-Q for the quarters ended March 31, 2026 and June 30, 2026 and any other documents
More news about: Quanta Services, Inc.
Aug 03, 2026, 18:00 ET Frost & Sullivan Appoints Dr. Vinod K. Aggarwal as Chief Economist
CLARA, Calif., Aug. 3, 2026 /PRNewswire/ -- Frost & Sullivan today announced the appointment of Dr. Vinod K. Aggarwal as Chief Economist. Having collaborated with the company for more than two decades across a range of advisory and leadership roles, Dr. Aggarwal
More news about: Frost & Sullivan
Aug 03, 2026, 18:00 ET Frost & Sullivan Appoints Dr. Vinod K. Aggarwal as Chief Economist
CLARA, Calif., Aug. 3, 2026 /PRNewswire/ -- Frost & Sullivan today announced the appointment of Dr. Vinod K. Aggarwal as Chief Economist. Having collaborated with the company for more than two decades across a range of advisory and leadership roles, Dr. Aggarwal
More news about: Frost & Sullivan
Aug 03, 2026, 17:59 ET Rosen Law Firm Encourages PennyMac Financial Services, Inc. Investors to Inquire About Securities Class Action Investigation - PFSI
on the class action.What is this about: On January 29, 2026, PennyMac filed a Current Report with the Securities Exchange Commission on Form 8-K announcing PennyMac's fourth quarter and full-year 2025 financial results. The report stated that PennyMac's "servicing segment pretax income was $37.3 million,
More news about: THE ROSEN LAW FIRM, P. A.
Aug 03, 2026, 17:56 ET Rosen Law Firm Encourages Elauwit Connection, Inc. Investors to Inquire About Securities Class Action Investigation - ELWT
action.What is this about: On February 27, 2026, during market hours, Elauwit filed a Current Report with the Securities and Exchange Commission on Form 8-K announcing non-reliance on "previously issued interim financial statements included in the Company's Quarterly Report on Form 10-Q for the quarter ended
More news about: THE ROSEN LAW FIRM, P. A.
Aug 03, 2026, 17:56 ET TETRA TECHNOLOGIES, INC. REPORTS STRONG SECOND-QUARTER 2026 RESULTS
factors described in the section titled "Risk Factors" contained in the Company's Annual Reports on Form 10-K, as well as other risks identified from time to time in its reports on Form 10-Q and Form 8-K filed with the Securities and Exchange Commission. Investors should not place undue reliance on forward-looking
More news about: TETRA Technologies, Inc.
Aug 03, 2026, 17:49 ET Rosen Law Firm Encourages TruBridge, Inc. Investors to Inquire About Securities Class Action Investigation - TBRG
previously issued consolidated financial statements for the years ended December 31, 2024 and December 31, 2023, filed with its Annual Reports on Form 10-K for the years then ended, in order to recognize certain of such revenues, costs and expenses in the appropriate fiscal year."On this news, TruBridge's
More news about: THE ROSEN LAW FIRM, P. A.
Aug 03, 2026, 17:48 ET Standlee Launches Forage Foundation™ to Advance the Role of Forage in Equine Nutrition
https://www.dropbox.com/scl/fo/1hcjb6jl297jox4mgmqtl/AH0mTiHu_wP4fsqUsjwGc4Q?rlkey=2r785jzeja7w5qtuxtxfr8p9k&st=a2ffo43q&dl=0About Standlee Founded in 1981, Standlee is a family-owned leader
More news about: Standlee
Aug 03, 2026, 17:42 ET Trilogy Metals Provides an Update on the Strategic Equity Investment by the U.S. Department of War
drilling results and geological tests, unexpected cost increases and other risks and uncertainties disclosed in the Company's Annual Report on Form 10-K for the year ended November 30, 2025 filed with Canadian securities regulatory authorities and with the United States Securities and Exchange Commission
More news about: Trilogy Metals Inc.
Aug 03, 2026, 17:20 ET RBLX Deadline: RBLX Investors with Losses in Excess of $100K Have Opportunity to Lead Roblox Corporation Securities Fraud Lawsuit
multimedia:https://www.prnewswire.com/news-releases/rblx-deadline-rblx-investors-with-losses-in-excess-of-100k-have-opportunity-to-lead-roblox-corporation-securities-fraud-lawsuit-302841572.htmlSOURCE
More news about: THE ROSEN LAW FIRM, P. A.
Aug 03, 2026, 17:00 ET BWXT Selling Medical Business to Nordic Capital in Transaction Valued at up to $800 Million
may vary materially from those expressed. For a more complete discussion of these and other risk factors, please see BWXT's annual report on Form 10-K for the year ended December 31, 2025, and subsequent quarterly reports on Form 10-Q filed with the Securities and Exchange Commission. BWXT cautions not
More news about: Nordic Capital
Aug 03, 2026, 16:30 ET JELD-WEN Reports Second Quarter 2026 Results and Updates Guidance
actual results to differ materially. For a discussion of these risks and uncertainties and other factors, please refer to our Annual Report on Form 10-K for the year ended December 31, 2025, Quarterly Reports on Form 10-Q filed in 2026 and our other filings with the U.S. Securities and Exchange Commission.The
More news about: JELD-WEN Holding, Inc.
Aug 03, 2026, 16:15 ET Peter Graham to join Invesco Mortgage Capital Inc. Board of Directors
Financial Condition and Results of Operations" in our annual report on Form 10-K for the year ended December 31, 2025, which may be updated by subsequently filed quarterly reports on Form 10-Q or current reports on Form 8-K, which are available on the Securities and Exchange Commission's website at
More news about: Invesco Mortgage Capital Inc.
Aug 03, 2026, 16:15 ET CACI Partners with Oracle to Deliver Federal Human Resources IT Modernization to the Office of Personnel Management
actual results to differ materially from those anticipated include, but are not limited to, the risk factors set forth in CACI's Annual Report on Form 10-K for the fiscal year ended June 30, 2025, and other such filings that CACI makes with the Securities and Exchange Commission from time to time. Any forward-looking
More news about: CACI International Inc
Aug 03, 2026, 16:15 ET Danaher Appoints Julie Sawyer Montgomery as President and Chief Executive Officer
actual results to differ materially from these forward-looking statements is available in our SEC filings, including our 2025 Annual Report on Form 10-K and Quarterly Report on Form 10-Q for the second quarter of 2026. These forward-looking statements speak only as of the date of this release and except
More news about: Danaher Corporation
Aug 03, 2026, 16:15 ET Centerspace Reports Second Quarter 2026 Financial & Operating Results and Updates Financial Outlook Due to Disposition Activity
"Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Risk Factors" contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2025, in its subsequent quarterly reports on Form 10-Q, and in other reports the Company files with the SEC from time
More news about: Centerspace
Aug 03, 2026, 16:10 ET Alexandria Real Estate Equities, Inc. Reports 2Q26 and 1H26 Net (Loss) Income per Share - Diluted of $(0.43) and $1.68, respectively, and 2Q26 and 1H26 FFO per Share - Diluted, as Adjusted, of $1.73 and $3.46, respectively
discussion of "forward-looking statements" in this Earnings Press Release as well as our SEC filings, including our most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q.
More news about: Alexandria Real Estate Equities, Inc.
Aug 03, 2026, 16:10 ET Metallus Announces Second-Quarter 2026 Results
Following the completion of the salaried pension plan annuitization in May 2024, there were surplus assets which were used to make a one-time 401(k) contribution to eligible employees. As a result, the Company recognized a loss of $3.6 million when the remaining assets were distributed.
More news about: Metallus Inc.
Aug 03, 2026, 16:10 ET Clorox Reports Q4 and FY26 Results, Provides FY27 Outlook
"Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the company's Annual Report on Form 10-K for the fiscal year ended June 30, 2025, as updated from time to time in the company's Securities and Exchange Commission filings. These factors include,
More news about: The Clorox Company
Aug 03, 2026, 16:05 ET Jazz Pharmaceuticals Announces Second Quarter 2026 Financial Results
second interim OS data from the Phase 3 HERIZON trial of zanidatamab in 1L GEA and top-line data from the Phase 3 ACTION trial of Modeyso in recurrent H3 K27M-mutant diffuse glioma; the company's expectations with respect to its preclinical research collaboration, option and license agreement with AbCellera;
More news about: Jazz Pharmaceuticals plc
Aug 03, 2026, 16:05 ET Jazz Pharmaceuticals Announces Second Quarter 2026 Financial Results
second interim OS data from the Phase 3 HERIZON trial of zanidatamab in 1L GEA and top-line data from the Phase 3 ACTION trial of Modeyso in recurrent H3 K27M-mutant diffuse glioma; the company's expectations with respect to its preclinical research collaboration, option and license agreement with AbCellera;
More news about: Jazz Pharmaceuticals plc